BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18186042)

  • 1. FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.
    Kwiatkowski BA; Kirillova I; Richard RE; Israeli D; Yablonka-Reuveni Z
    J Cell Physiol; 2008 Jun; 215(3):803-17. PubMed ID: 18186042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptors display both common and distinct signaling pathways.
    Shaoul E; Reich-Slotky R; Berman B; Ron D
    Oncogene; 1995 Apr; 10(8):1553-61. PubMed ID: 7731710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
    Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
    Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sp3 controls fibroblast growth factor receptor 4 gene activity during myogenic differentiation.
    Cavanaugh E; DiMario JX
    Gene; 2017 Jun; 617():24-31. PubMed ID: 28359915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile and overexpression outcome indicate a role for βKlotho in skeletal muscle fibro/adipogenesis.
    Phelps M; Stuelsatz P; Yablonka-Reuveni Z
    FEBS J; 2016 May; 283(9):1653-68. PubMed ID: 26881702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into FGFR kinase isoform selectivity: diverse binding modes of AZD4547 and ponatinib in complex with FGFR1 and FGFR4.
    Tucker JA; Klein T; Breed J; Breeze AL; Overman R; Phillips C; Norman RA
    Structure; 2014 Dec; 22(12):1764-1774. PubMed ID: 25465127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of TGFβ2, WNT9a, and FGFR4 signals attenuate satellite cell differentiation during skeletal muscle development.
    Zhang W; Xu Y; Zhang L; Wang S; Yin B; Zhao S; Li X
    Aging Cell; 2018 Aug; 17(4):e12788. PubMed ID: 29869452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.
    Sahadevan K; Darby S; Leung HY; Mathers ME; Robson CN; Gnanapragasam VJ
    J Pathol; 2007 Sep; 213(1):82-90. PubMed ID: 17607666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
    Cornish EE; Natoli RC; Hendrickson A; Provis JM
    Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.
    Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S
    J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy.
    Quintanal-Villalonga Á; Ferrer I; Guruceaga E; Cirauqui C; Marrugal Á; Ojeda L; García S; Zugazagoitia J; Muñoz-Galván S; Lopez-Rios F; Montuenga L; Vicent S; Molina-Pinelo S; Carnero A; Paz-Ares L
    EBioMedicine; 2020 Mar; 53():102683. PubMed ID: 32114392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
    Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical studies on FGFR isoform selectivity of FGFR1/FGFR4 inhibitors by molecular dynamics simulations and free energy calculations.
    Fu W; Chen L; Wang Z; Kang Y; Wu C; Xia Q; Liu Z; Zhou J; Liang G; Cai Y
    Phys Chem Chem Phys; 2017 Feb; 19(5):3649-3659. PubMed ID: 28094372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE
    Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of the human fibroblast growth factor receptor 4 kinase.
    Lesca E; Lammens A; Huber R; Augustin M
    J Mol Biol; 2014 Nov; 426(22):3744-3756. PubMed ID: 25219510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF6 modulates the expression of fibroblast growth factor receptors and myogenic genes in muscle cells.
    Pizette S; Coulier F; Birnbaum D; DeLapeyrière O
    Exp Cell Res; 1996 Apr; 224(1):143-51. PubMed ID: 8612679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.
    Ezzat S; Zheng L; Winer D; Asa SL
    Mol Endocrinol; 2006 Nov; 20(11):2965-75. PubMed ID: 16857743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of developing dental tissues to fibroblast growth factors: expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9.
    Kettunen P; Karavanova I; Thesleff I
    Dev Genet; 1998; 22(4):374-85. PubMed ID: 9664689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney.
    Cancilla B; Ford-Perriss MD; Bertram JF
    Kidney Int; 1999 Dec; 56(6):2025-39. PubMed ID: 10594778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
    Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
    World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.